prediabetes diabetes
Conditions
Interventions
Experimental:glucose+Iminonorm
Experimental:maltose+Iminonorm
Experimental:sucrose+Iminororm
Experimental :maltodextrin+Iminororm
Sponsors
The 2nd Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Healthy participants aged 18 to 40; 2. BMI ranged between 18 to 25; 3. No previous diagnosis of diabetes or pre-diabetes, FBG ranged between 3.9 to 5.5 mmol/L or 70 to 100 mg/dl; 4. No previous use of anti-diabetic or anti-insulin-resistance agents; 5. Voluntary consent to the study.
Exclusion criteria
Exclusion criteria: 1. Abnormal findings physical examinations, blood urine tests, EGG, with clinical significance; 2. Pregnancy or lactation; 3. History of primary liver, kidney heart diseases, digestive metabolism disorders or nervous tem diseases; 4. Dibility, physically or mentally; 5. Known allergy to any drug or food, to iminonorm components or their derivatives; 6. History or evidence of malignancy; 7. Use of any drug with known harms to human organs to 3 months prior to enrollment or use of any drug within 2 weeks prior to enrollment; 8. Other conditions that may interfere with observation on drug absorption, distribution, excretion metabolism; 9. Participation in any other clinical trial within 3 months prior to enrollment; 10. Other factors that disqualify the subject participation as judged by the recruiting staff.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood glucose;glycemic index; | — |
Countries
China
Contacts
Public ContactYuhong Huang
Outcome results
None listed